UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Ductal Carcinoma In Situ Biology, Biomarkers, and Diagnosis

Frontiers in oncology, 2017-10, Vol.7, p.248-248

2017

Volltextzugriff (PDF)

Evaluating statistical approaches to define clonal origin of tumours using bulk DNA sequencing: context is everything

Genome Biology, 2022-02, Vol.23 (1), p.43-43, Article 43

2022

Volltextzugriff (PDF)

CONTRA: copy number analysis for targeted resequencing

Bioinformatics (Oxford, England), 2012-05, Vol.28 (10), p.1307-1313

2012

Volltextzugriff (PDF)

Atypical ductal hyperplasia: update on diagnosis, management, and molecular landscape

Breast cancer research : BCR, 2018-05, Vol.20 (1), p.39-39, Article 39

2018

Volltextzugriff (PDF)

Gender differences in publication output: towards an unbiased metric of research performance

PloS one, 2006-12, Vol.1 (1), p.e127-e127

2006

Volltextzugriff (PDF)

When Is "Type I" Ovarian Cancer Not "Type I"? Indications of an Out-Dated Dichotomy

Frontiers in oncology, 2018-12, Vol.8, p.654-654

2018

Volltextzugriff (PDF)

The clinical and biological significance of HER2 over-expression in breast ductal carcinoma in situ: a large study from a single institution

British journal of cancer, 2019-05, Vol.120 (11), p.1075-1082

2019

Volltextzugriff (PDF)

Exome sequencing of familial high-grade serous ovarian carcinoma reveals heterogeneity for rare candidate susceptibility genes

Nature communications, 2020-04, Vol.11 (1), p.1640-1640, Article 1640

2020

Volltextzugriff (PDF)

The Protein Landscape of Mucinous Ovarian Cancer: Towards a Theranostic

Cancers, 2021-11, Vol.13 (22), p.5596

2021

Volltextzugriff (PDF)

Identification of candidate growth promoting genes in ovarian cancer through integrated copy number and expression analysis

PloS one, 2010-04, Vol.5 (4), p.e9983-e9983

2010

Volltextzugriff (PDF)

IL6-STAT3-HIF Signaling and Therapeutic Response to the Angiogenesis Inhibitor Sunitinib in Ovarian Clear Cell Cancer

Clinical cancer research, 2011-04, Vol.17 (8), p.2538-2548

2011

Volltextzugriff (PDF)

Molecular analysis of PALB2‐associated breast cancers

The Journal of pathology, 2018-05, Vol.245 (1), p.53-60

2018

Volltextzugriff (PDF)

Mutational landscape of mucinous ovarian carcinoma and its neoplastic precursors

Genome medicine, 2015-08, Vol.7 (1), p.87-87, Article 87

2015

Volltextzugriff (PDF)

Stromal lymphocytes are associated with upgrade of B3 breast lesions

Breast cancer research : BCR, 2024-07, Vol.26 (1), p.1-10, Article 115

2024

Volltextzugriff (PDF)

Amplicon-dependent CCNE1 expression is critical for clonogenic survival after cisplatin treatment and is correlated with 20q11 gain in ovarian cancer

PloS one, 2010-11, Vol.5 (11), p.e15498

2010

Volltextzugriff (PDF)

Thioredoxin-interacting protein is an independent risk stratifier for breast ductal carcinoma in situ

Modern pathology, 2018-12, Vol.31 (12), p.1807-1815

2018

Volltextzugriff (PDF)

Breast ductal carcinoma in situ carry mutational driver events representative of invasive breast cancer

Modern pathology, 2017-07, Vol.30 (7), p.952-963

2017

Volltextzugriff (PDF)

Pre-Invasive Ovarian Mucinous Tumors Are Characterized by CDKN2A and RAS Pathway Aberrations

Clinical cancer research, 2012-10, Vol.18 (19), p.5267-5277

2012

Volltextzugriff (PDF)

High-Resolution Single Nucleotide Polymorphism Array Analysis of Epithelial Ovarian Cancer Reveals Numerous Microdeletions and Amplifications

Clinical cancer research, 2007-08, Vol.13 (16), p.4731-4739

2007

Volltextzugriff (PDF)

Evaluating the breast cancer predisposition role of rare variants in genes associated with low-penetrance breast cancer risk SNPs

Breast cancer research : BCR, 2018-01, Vol.20 (1), p.3-3, Article 3

2018

Volltextzugriff (PDF)

Germline whole exome sequencing of a family with appendiceal mucinous tumours presenting with pseudomyxoma peritonei

BMC cancer, 2020-05, Vol.20 (1), p.369-369, Article 369

2020

Volltextzugriff (PDF)

Targeted therapy for mucinous ovarian carcinoma: evidence from clinical trials

International journal of gynecological cancer, 2023-01, Vol.33 (1), p.102-108

2023

Volltextzugriff (PDF)

Clinical and biological roles of Kelch-like family member 7 in breast cancer: a marker of poor prognosis

Breast cancer research and treatment, 2018-08, Vol.170 (3), p.525-533

2018

Volltextzugriff (PDF)

Prevalence of PALB2 mutations in Australian familial breast cancer cases and controls

Breast cancer research : BCR, 2015-08, Vol.17 (1), p.111-111, Article 111

2015

Volltextzugriff (PDF)

Functional and genomic characterisation of a xenograft model system for the study of metastasis in triple-negative breast cancer

Disease models & mechanisms, 2018-05, Vol.11 (5)

2018

Volltextzugriff (PDF)

1 – 25 von 121

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(117)
Mit Volltextzugriff
(115)

Publikationsform

Artikel
(119)
Buchkapitel
(2)

Sprache

Englisch
(121)
Japanisch
(20)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Clinical Cancer Research
(11)
Histopathology
(9)
Modern Pathology
(8)
Breast Cancer Research And Treatment
(7)
Plos One
(7)
The Journal Of Pathology
(7)
Journal Of Pathology
(6)
Npj Breast Cancer
(6)
Bmc Cancer
(5)
Breast Cancer Research : Bcr
(5)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Ductal Carcinoma In Situ Biology, Biomarkers, and Diagnosis

Evaluating statistical approaches to define clonal origin of tumours using bulk DNA sequencing: context is everything

CONTRA: copy number analysis for targeted resequencing

Atypical ductal hyperplasia: update on diagnosis, management, and molecular landscape

Gender differences in publication output: towards an unbiased metric of research performance

When Is "Type I" Ovarian Cancer Not "Type I"? Indications of an Out-Dated Dichotomy

The clinical and biological significance of HER2 over-expression in breast ductal carcinoma in situ: a large study from a single institution

Exome sequencing of familial high-grade serous ovarian carcinoma reveals heterogeneity for rare candidate susceptibility genes

The Protein Landscape of Mucinous Ovarian Cancer: Towards a Theranostic

Identification of candidate growth promoting genes in ovarian cancer through integrated copy number and expression analysis

IL6-STAT3-HIF Signaling and Therapeutic Response to the Angiogenesis Inhibitor Sunitinib in Ovarian Clear Cell Cancer

Molecular analysis of PALB2‐associated breast cancers

Mutational landscape of mucinous ovarian carcinoma and its neoplastic precursors

Stromal lymphocytes are associated with upgrade of B3 breast lesions

Amplicon-dependent CCNE1 expression is critical for clonogenic survival after cisplatin treatment and is correlated with 20q11 gain in ovarian cancer

Thioredoxin-interacting protein is an independent risk stratifier for breast ductal carcinoma in situ

Breast ductal carcinoma in situ carry mutational driver events representative of invasive breast cancer

Pre-Invasive Ovarian Mucinous Tumors Are Characterized by CDKN2A and RAS Pathway Aberrations

High-Resolution Single Nucleotide Polymorphism Array Analysis of Epithelial Ovarian Cancer Reveals Numerous Microdeletions and Amplifications

Evaluating the breast cancer predisposition role of rare variants in genes associated with low-penetrance breast cancer risk SNPs

Germline whole exome sequencing of a family with appendiceal mucinous tumours presenting with pseudomyxoma peritonei

Targeted therapy for mucinous ovarian carcinoma: evidence from clinical trials

Clinical and biological roles of Kelch-like family member 7 in breast cancer: a marker of poor prognosis

Prevalence of PALB2 mutations in Australian familial breast cancer cases and controls

Functional and genomic characterisation of a xenograft model system for the study of metastasis in triple-negative breast cancer

Suchergebnisse filtern